Workflow
健康元(600380) - 2025 Q3 - 季度财报
2025-10-24 13:45
Financial Performance - Revenue for the third quarter was CNY 3,579,478,699.21, a decrease of 2.31% compared to the same period last year[5] - Total profit for the quarter was CNY 779,993,613.25, down 6.84% year-on-year[5] - Net profit attributable to shareholders was CNY 306,274,217.94, reflecting an 8.61% decline compared to the previous year[5] - The company reported a basic earnings per share of CNY 0.17, a decrease of 5.56% from the same quarter last year[5] - Total operating revenue for the first three quarters of 2025 was CNY 11,477,806,949.62, a decrease of 3.53% compared to CNY 11,898,828,905.02 in the same period of 2024[22] - Net profit for the first three quarters of 2025 was CNY 2,444,561,495.06, slightly up from CNY 2,433,696,525.07 in 2024, reflecting a growth of 0.01%[22] - Earnings per share (EPS) for the first three quarters of 2025 was CNY 0.60, compared to CNY 0.59 in the same period of 2024[23] Assets and Liabilities - Total assets increased by 0.83% to CNY 36,013,652,752.26 compared to the end of last year[7] - As of September 30, 2025, the total assets of the company amounted to RMB 36,013,652,752.26, an increase from RMB 35,718,129,456.13 as of December 31, 2024[19] - The company's cash and cash equivalents stood at RMB 14,516,558,903.45, slightly down from RMB 14,851,977,121.94 in the previous year[19] - Accounts receivable increased to RMB 2,840,521,242.56 from RMB 2,429,891,052.01, reflecting a growth of approximately 16.9%[19] - Inventory decreased to RMB 2,304,853,727.18 from RMB 2,621,343,117.50, indicating a reduction of about 12.1%[19] - The company's long-term equity investments rose to RMB 1,488,646,760.50 from RMB 1,446,298,598.46, showing an increase of approximately 2.9%[19] - Total liabilities decreased to CNY 11,931,050,847.58 from CNY 12,317,986,676.85, a reduction of 3.14%[20] - The total equity increased to CNY 24,082,601,904.68, up from CNY 23,400,142,779.28, reflecting a growth of 2.92%[20] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 3,001,401,972.07, an increase of 14.84%[5] - In the first three quarters of 2025, the net cash flow from operating activities was CNY 3,001,401,972.07, an increase of 14.8% compared to CNY 2,613,605,501.06 in the same period of 2024[25] - Total cash inflow from investment activities in the first three quarters of 2025 was CNY 6,596,011,475.83, significantly higher than CNY 715,126,794.74 in 2024[25] - The net cash flow from financing activities for the first three quarters of 2025 was -CNY 1,885,905,046.43, an improvement from -CNY 2,147,617,457.61 in 2024[26] - The total cash and cash equivalents at the end of Q3 2025 stood at CNY 14,507,137,859.82, slightly down from CNY 14,585,469,820.67 at the end of Q3 2024[26] - Cash received from sales of goods and services in the first three quarters of 2025 was CNY 12,391,479,624.95, a decrease of 4.3% from CNY 12,943,223,324.92 in 2024[25] - Cash outflow for purchasing goods and services was CNY 3,345,995,774.10 in 2025, down from CNY 3,827,753,296.70 in 2024, indicating a reduction of 12.5%[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 81,433[13] - The largest shareholder, Shenzhen Baiye Yuan Investment Co., Ltd., holds 48.96% of the shares[13] - The company has no related party relationships among the top shareholders, ensuring independent operations[19] Development and Investment - The company’s development expenditure increased by 42.42% to CNY 516,552,277.31, attributed to increased investment in clinical trials[12] - The company reported a decrease in research and development expenses to CNY 931,015,773.09, down from CNY 1,036,376,310.06 in the previous year, indicating a reduction of 10.14%[22] - The company’s investment income increased to CNY 64,826,880.04, up from CNY 51,650,239.89 year-over-year, indicating a growth of 25.49%[22] Other Financial Metrics - The company’s weighted average return on equity was 2.08%, a decrease of 0.24 percentage points year-on-year[5] - The company’s financial expenses showed a significant change, with a net financial income of CNY -262,734,133.56 compared to CNY -105,969,421.63 in the previous year[22] - Other comprehensive income after tax for the first three quarters of 2025 was CNY -78,933,476.63, an improvement from CNY -86,688,069.37 in the same period of 2024[23] - The cash flow from investment activities showed a net outflow of -CNY 1,353,419,011.00 in 2025, compared to -CNY 1,183,961,052.92 in 2024[25] - The cash flow from operating activities was impacted by a total outflow of CNY 9,995,244,707.42 in 2025, down from CNY 10,853,237,087.15 in 2024[25] - The company reported a decrease in cash flow due to foreign exchange fluctuations, with an impact of -CNY 97,585,733.14 in 2025 compared to -CNY 37,426,542.59 in 2024[26]
金洲管道(002443) - 2025 Q3 - 季度财报
2025-10-24 13:40
浙江金洲管道科技股份有限公司 2025 年第三季度报告 证券代码:002443 证券简称:金洲管道 公告编号:2025-038 浙江金洲管道科技股份有限公司 2025 年第三季度报告 本公司及除董事周学民外的董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 董事周学民因公司 2025 年第三季度报告未经会计师事务所审计,不能保证公告内容真实、准确、完 整。 重要内容提示: 1.董事会、监事会及除周学民外的董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 董事周学民因公司 2025 年第三季度报告未经会计师事务所审计,无法保证季度报告内容的真实、准确、 完整。请投资者特别关注。 □是 否 1 浙江金洲管道科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是否 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 ...
惠泰医疗(688617) - 2025 Q3 - 季度财报
2025-10-24 13:40
Financial Performance - The company's operating revenue for Q3 2025 reached ¥653,632,554.76, representing a year-on-year increase of 24.77%[4] - Total profit for the period was ¥226,411,257.18, reflecting a growth of 14.06% compared to the same period last year[4] - Net profit attributable to shareholders was ¥198,142,814.88, which is a 6.77% increase year-on-year[4] - Basic earnings per share (EPS) for the period was ¥1.41, a 6.82% increase compared to the same period last year[4] - Total operating revenue for the first three quarters of 2025 reached ¥1,867,437,461.29, an increase of 22.5% compared to ¥1,524,828,925.89 in the same period of 2024[19] - Operating profit for the first three quarters of 2025 was ¥710,662,982.14, up from ¥589,309,852.67 in 2024, reflecting a growth of 20.5%[19] - Net profit attributable to the parent company for the first three quarters of 2025 was ¥623,303,796.09, compared to ¥528,146,736.78 in 2024, indicating a year-over-year increase of 18.0%[20] - The company reported a net profit of ¥614,819,029.79 for the first three quarters of 2025, compared to ¥522,050,612.64 in 2024, showing an increase of 17.7%[20] Research and Development - Research and development (R&D) expenses totaled ¥97,912,145.14, marking a significant increase of 41.98% compared to the previous year[5] - R&D expenses accounted for 14.98% of operating revenue, an increase of 1.82 percentage points from the previous year[5] - Research and development expenses for the first three quarters of 2025 were ¥255,144,492.49, compared to ¥202,856,157.35 in 2024, reflecting an increase of 25.7%[19] Assets and Liabilities - The company's total assets increased to ¥3,460,753,039.96, up 16.11% from the end of the previous year[5] - Total assets as of September 30, 2025, amounted to ¥3,460,753,039.96, up from ¥2,980,697,768.82 at the end of 2024, representing a growth of 16.1%[17] - The company's total liabilities as of September 30, 2025, were ¥423,502,726.05, slightly down from ¥425,854,466.29 at the end of 2024[17] - Non-current liabilities increased to ¥55,823,394.66 as of September 30, 2025, from ¥19,885,806.72 at the end of 2024, marking a significant rise of 180.5%[17] Cash Flow - The net cash flow from operating activities was ¥231,410,546.53, showing a growth of 28.30% year-on-year[4] - In the first three quarters of 2025, the cash inflow from operating activities was CNY 2,143,203,311.23, an increase of 25.9% compared to CNY 1,702,544,374.27 in the same period of 2024[23] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 676,059,199.46, up 29.0% from CNY 523,837,422.35 in 2024[23] - The cash outflow from investment activities in the first three quarters of 2025 totaled CNY 2,329,491,613.40, compared to CNY 1,239,935,538.94 in 2024, indicating a significant increase[24] - The net cash flow from investment activities was -CNY 593,778,301.10 in 2025, an improvement from -CNY 877,740,822.75 in 2024[24] - The cash inflow from financing activities in the first three quarters of 2025 was CNY 43,776,853.78, down from CNY 69,759,005.08 in 2024[24] - The net cash flow from financing activities was -CNY 187,638,264.54 in 2025, an improvement from -CNY 320,399,560.82 in 2024[24] - The ending balance of cash and cash equivalents as of September 30, 2025, was CNY 974,854,369.21, compared to CNY 599,613,654.94 at the end of September 2024[24] - The company received CNY 1,731,078,765.88 in cash from investment recoveries in the first three quarters of 2025, a substantial increase from CNY 255,904,444.44 in 2024[23] - The cash paid for the acquisition of fixed assets and other long-term assets in 2025 was CNY 233,491,613.40, significantly lower than CNY 557,926,383.50 in 2024[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,690[12] - The largest shareholder, Shenzhen Mindray Technology Holdings Co., Ltd., holds 32,508,228 shares, representing 23.05% of total shares[12] - The second-largest shareholder, Cheng Zhenghui, holds 23,551,232 shares, accounting for 16.70%[12] - The company has no significant changes in the top 10 shareholders or their shareholding status due to margin trading[13] Company Strategy and Outlook - The company plans to continue enhancing its product portfolio and increasing investment in new product and technology development[10] - There are no other significant reminders regarding the company's operational situation during the reporting period[14] - The company has not reported any new strategies or product developments in the conference call[14] Accounting Standards - The company did not apply new accounting standards for the first time in 2025[25]
海泰新光(688677) - 2025 Q3 - 季度财报
2025-10-24 13:40
Financial Performance - The company's operating revenue for Q3 2025 reached ¥182,026,942.33, representing an increase of 85.26% compared to the same period last year[3] - The total profit for the period was ¥70,634,060.83, marking a significant increase of 140.41% year-over-year[3] - Net profit attributable to shareholders was ¥61,930,727.98, up 130.72% from the previous year[3] - The net profit excluding non-recurring gains and losses was ¥60,869,867.83, reflecting a 148.40% increase year-over-year[3] - The company reported a basic earnings per share of ¥0.52, which is a 136.36% increase compared to the same period last year[3] - Total operating revenue for the first three quarters of 2025 reached RMB 447.64 million, a significant increase of 40.4% compared to RMB 318.67 million in the same period of 2024[19] - Net profit for the first three quarters of 2025 was RMB 133.32 million, up 38.3% from RMB 96.42 million in the first three quarters of 2024[20] - Basic and diluted earnings per share for the first three quarters of 2025 were both RMB 1.14, compared to RMB 0.81 in 2024, marking a growth of 40.7%[21] - The total profit for the first three quarters of 2025 was RMB 155.56 million, an increase of 42% from RMB 109.59 million in 2024[20] - The company’s total comprehensive income for the first three quarters of 2025 was RMB 132.35 million, compared to RMB 96.35 million in 2024, reflecting a growth of 37.4%[21] Research and Development - Research and development (R&D) expenses totaled ¥18,368,797.26, accounting for 10.09% of operating revenue, a decrease of 6.54 percentage points from the previous year[4] - Research and development expenses increased to RMB 51.58 million in 2025, compared to RMB 47.15 million in 2024, reflecting a growth of 9.2%[19] Cash Flow and Assets - The company experienced a 35.43% increase in net cash flow from operating activities, totaling ¥124,294,919.71 for the year-to-date[3] - The net cash flow from operating activities for the first three quarters of 2025 was RMB 124.29 million, an increase of 35.3% from RMB 91.78 million in 2024[23] - The company reported a net cash increase of RMB 38.38 million in the first three quarters of 2025, contrasting with a decrease of RMB 157.49 million in the same period of 2024[24] Assets and Liabilities - Total assets increased by 9.62% to ¥1,600,568,048.20 compared to the end of the previous year[4] - As of September 30, 2025, the total assets of the company amounted to ¥1,600,568,048.20, an increase from ¥1,460,092,283.49 in the previous year[15] - The company's cash and cash equivalents reached ¥562,193,728.74, up from ¥523,890,835.86 year-over-year[15] - Inventory increased to ¥229,778,396.19 from ¥186,514,537.63, reflecting a growth of approximately 23.1%[16] - Total liabilities rose to ¥283,385,589.73 compared to ¥154,641,332.66 in the previous year, indicating a significant increase[17] - The company's equity attributable to shareholders was ¥1,317,659,571.54, slightly up from ¥1,303,492,801.58[17] - The company reported a total of ¥114,972,424.80 in accounts receivable, a decrease from ¥119,332,508.50[16] - The company has a short-term loan of ¥70,000,000.00, which was not present in the previous year[16] - The company’s long-term investments decreased to ¥42,604,666.89 from ¥53,523,671.16[16] - The company’s total current assets amounted to ¥981,093,687.06, an increase from ¥851,290,383.20[16] Revenue Drivers - The growth in revenue was primarily driven by significant increases in the sales of medical endoscopes and optical products, with both segments showing strong performance[10] Operating Costs - Total operating costs for the first three quarters of 2025 were RMB 281.98 million, up 35% from RMB 208.94 million in 2024[19] Investment Activities - The company experienced an investment cash flow net loss of RMB 74.44 million in 2025, an improvement from a loss of RMB 160.81 million in 2024[24] Shareholder Information - The company has not reported any significant changes in the top ten shareholders or their participation in margin trading[14]
江苏金租(600901) - 2025 Q3 - 季度财报
2025-10-24 13:40
Financial Performance - The company's operating revenue for the third quarter reached CNY 163,192.47 million, an increase of 21.51% compared to the same period last year[5] - The net profit attributable to shareholders was CNY 88,161.73 million, reflecting an 11.24% year-on-year growth[5] - The net profit after deducting non-recurring gains and losses was CNY 87,744.21 million, up by 11.02% year-on-year[5] - Net profit for the first three quarters of 2025 reached ¥2.45 billion, compared to ¥2.23 billion in the same period of 2024, reflecting a year-over-year increase of 9.9%[26] - Operating income for the first three quarters of 2025 was ¥4.64 billion, an increase of 17.2% from ¥3.96 billion in the first three quarters of 2024[26] - The company reported a net interest income of ¥4.72 billion for the first three quarters of 2025, compared to ¥3.89 billion in the same period of 2024, an increase of 21.4%[26] Assets and Liabilities - Total assets increased by 18.04% year-to-date, reaching CNY 16,201,113.36 million[6] - Total assets increased to RMB 16,201,113.36 million, up from RMB 13,725,477.82 million year-over-year, representing a growth of approximately 17.9%[16] - Total liabilities rose to RMB 13,654,876.09 million, compared to RMB 11,267,333.66 million in the previous year, marking an increase of about 21.1%[16] - Total liabilities amounted to ¥136.55 billion as of September 30, 2025, up from ¥112.67 billion at the end of 2024, indicating a growth of 21.2%[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 59,022[12] - The total equity attributable to shareholders increased to ¥25.01 billion as of September 30, 2025, from ¥24.13 billion at the end of 2024, a growth of 3.6%[25] Earnings Per Share - The basic earnings per share for the quarter was CNY 0.15, a decrease of 16.67% compared to the previous year[6] - Basic earnings per share (EPS) for the first three quarters of 2025 is CNY 0.42, compared to CNY 0.51 in the same period of 2024[28] - Diluted earnings per share (EPS) increased to CNY 0.42 from CNY 0.40 year-over-year[28] Cash Flow - The company reported a net cash flow from operating activities of CNY -428,139.07 million year-to-date[5] - Net cash flow from operating activities for the first three quarters of 2025 is -CNY 4.28 billion, a decline from -CNY 1.11 billion in the same period of 2024[28] - Total cash inflow from operating activities reached CNY 81.99 billion, up from CNY 66.91 billion year-over-year[28] - Cash outflow from operating activities increased to CNY 86.27 billion from CNY 68.02 billion in the previous year[28] - Cash flow from investing activities resulted in a net outflow of CNY 31.77 million, compared to a net outflow of CNY 724.26 million in 2024[29] - Cash flow from financing activities generated a net inflow of CNY 2.71 billion, compared to CNY 1.33 billion in the same period of 2024[29] - The ending cash and cash equivalents balance for the first three quarters of 2025 is CNY 3.21 billion, up from CNY 2.33 billion in 2024[29] Non-Recurring Gains and Losses - Non-recurring gains totaled CNY 417.52 million for the quarter, with government subsidies contributing CNY 133.04 million[10] Capital Adequacy and Ratios - The weighted average return on equity decreased by 0.59 percentage points to 3.59%[6] - The company's core Tier 1 capital adequacy ratio decreased to 16.02% from 17.91% year-over-year[18] - The provision coverage ratio decreased to 403.01% from 430.27% year-over-year[19] - The non-performing financing lease asset ratio improved slightly to 0.90% from 0.91% year-over-year[19] - The net interest margin for leasing business increased to 3.75% from 3.67% year-over-year[19] Leasing Assets - The total amount of receivable lease payments reached RMB 14,749,560.42 million, up from RMB 12,348,281.03 million year-over-year[16] - The company reported a total of RMB 15,242,545.05 million in leasing assets, an increase from RMB 12,780,322.52 million year-over-year[22] - The proportion of normal classified assets increased to 96.90% from 96.34% year-over-year[21] Other Information - The company has not reported any changes in major shareholders or significant financing activities during the reporting period[14] - The company issued bonds worth CNY 6 billion in 2025, down from CNY 7 billion in 2024[29] - The company did not apply new accounting standards for the year 2025[30]
万里石(002785) - 2025 Q3 - 季度财报
2025-10-24 13:10
Revenue and Profit - The company's revenue for Q3 2025 reached ¥332,514,502.61, representing a year-over-year increase of 28.77%[5] - The net profit attributable to shareholders was a loss of ¥3,213,849.65, a decrease of 71.58% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥4,936,681.27, an increase of 20.31% year-over-year[5] - Total operating revenue for the current period reached ¥936,225,745.68, an increase of 2.7% compared to ¥911,253,133.24 in the previous period[20] - Operating profit for the current period was ¥3,420,629.72, a significant improvement from a loss of ¥9,015,371.04 in the previous period[21] - Net profit for the current period was -¥1,431,398.73, compared to -¥9,421,802.39 in the previous period, indicating a reduced loss[22] - The company reported a basic earnings per share of ¥0.0089, down from ¥0.0108 in the previous period[22] Cash Flow - The operating cash flow for the year-to-date period was ¥11,308,445.17, showing a significant increase of 130.38%[5] - The net cash flow from operating activities was ¥11,308,445.17, a recovery from a negative cash flow of -¥37,221,634.48 in the previous period[23] - The company generated cash inflows from operating activities totaling ¥1,041,977,339.69, compared to ¥963,181,493.08 in the previous period, marking an increase of 8.2%[23] - The net cash inflow from investment activities was $48,077,951.62, a significant improvement from a net outflow of $27,294,738.17 in the previous period[24] - Total cash inflow from financing activities amounted to $192,782,451.34, compared to $163,096,556.00 in the prior period, reflecting a growth of approximately 18%[24] - The net cash outflow from financing activities decreased to $9,928,131.57 from a net outflow of $55,272,875.01 in the previous period, indicating a positive shift in financing operations[24] - The cash and cash equivalents at the end of the period increased to $191,820,049.04, up from $179,049,985.99 in the previous period[24] - The company’s cash and cash equivalents net increase for the period was $68,956,160.56, contrasting with a net decrease of $120,251,110.17 in the prior period[24] Assets and Liabilities - The total assets as of September 30, 2025, were ¥1,612,654,611.49, down 1.48% from the end of the previous year[6] - The company's equity attributable to shareholders was ¥887,461,355.58, a slight decrease of 0.12% from the previous year-end[6] - Total current assets amount to 1,087,121,278.69 RMB, a decrease from 1,108,048,528.90 RMB at the beginning of the period[16] - Total liabilities decreased to ¥676,699,677.38 from ¥696,600,044.40, a reduction of approximately 2.9%[18] - Total current liabilities decreased to 656,423,408.65 RMB from 680,825,684.56 RMB[17] - The company has a long-term investment of 194,143,005.15 RMB, slightly down from 195,253,606.68 RMB[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,341[13] - The largest shareholder, Hu Jingpei, holds 12.37% of shares, amounting to 28,034,951 shares, with 13,200,000 shares pledged[13] Investment and Costs - The company reported a significant decrease in investment income, down 44.24% to ¥3,643,978.90, attributed to reduced earnings from equity investments[11] - Total operating costs amounted to ¥943,448,729.15, up from ¥915,105,074.50, reflecting a rise of 3.6%[21] - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets was $7,747,886.14, down from $27,360,158.17 in the previous period, showing a reduction of approximately 72%[24] Other Financial Metrics - The company experienced a 71.85% decrease in foreign currency translation differences, impacting the financial results negatively[11] - Deferred tax assets increased to 106,438,926.90 RMB from 104,493,449.20 RMB[17] - Deferred income decreased to ¥804,375.00 from ¥825,000.00, a decline of about 2.5%[18] - The cash outflow for debt repayment was $173,165,420.44, a decrease from $206,612,568.16 in the previous period, indicating improved cash management[24] - The impact of exchange rate changes on cash and cash equivalents was a negative $358,367.80, slightly better than the previous negative impact of $461,862.51[24]
哈三联(002900) - 2025 Q3 - 季度财报
2025-10-24 13:10
Financial Performance - The company's revenue for Q3 2025 was ¥167,526,697.03, a decrease of 46.83% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥116,451,164.25, representing a decline of 913.69% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥121,245,126.35, down 1,113.19% from the previous year[5]. - Total operating revenue for the current period was CNY 580,649,067.87, a decrease of 30.8% compared to CNY 838,525,846.47 in the previous period[19]. - The net profit for the current period was a loss of CNY 211,476,435.44, compared to a profit of CNY 37,498,969.48 in the previous period[19]. - The total comprehensive income amounted to -211,476,435.44 CNY, down from 37,498,969.48 CNY in the prior period[20]. - The basic and diluted earnings per share were both -0.66 CNY, compared to 0.13 CNY in the previous period[20]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,609,272,790.67, a decrease of 5.03% from the end of the previous year[5]. - Current assets totaled CNY 1,187,835,221.22, down from CNY 1,471,966,906.93, indicating a decrease of 19.3%[16]. - Non-current assets increased to CNY 2,421,437,569.45 from CNY 2,328,501,363.24, representing a growth of 4.0%[17]. - Total liabilities rose to CNY 1,704,282,058.15 from CNY 1,636,313,285.80, an increase of 4.1%[18]. - The total owner's equity decreased to CNY 1,904,990,732.52 from CNY 2,164,154,984.37, a decline of 12.0%[18]. Cash Flow - The company reported a significant increase in cash flow from operating activities, with a net cash flow of ¥27,645,727.39, up 161.27% year-to-date[5]. - Cash flow from operating activities generated a net inflow of 27,645,727.39 CNY, a recovery from a net outflow of -45,120,146.94 CNY in the prior period[22]. - Cash inflow from investment activities was 144,266,659.10 CNY, down from 225,785,193.74 CNY in the previous period[22]. - Cash outflow from investment activities totaled 316,908,290.76 CNY, compared to 504,051,443.94 CNY in the prior period[22]. - Cash flow from financing activities generated a net inflow of 231,513,898.50 CNY, compared to 304,959,417.97 CNY in the previous period[22]. - The ending cash and cash equivalents balance was 641,999,568.80 CNY, up from 523,931,302.90 CNY in the prior period[22]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 37,527, with no preferred shareholders[12]. - The largest shareholder, Qin Jianfei, holds 39.10% of shares, totaling 123,705,000 shares, with 21,000,000 shares pledged[13]. Expenses and Income - The company’s financial expenses surged by 3,555.24% to ¥12,782,675.20, primarily due to a decrease in interest income and loan subsidies[9]. - The investment income decreased by 34.75% to ¥16,629,941.00, attributed to reduced earnings from affiliated companies[9]. - The company’s public value change loss was -¥9,770,148.86, reflecting a further decline in the fair value of securities investments[9]. - Credit impairment losses increased by 783.77% to CNY 1,754,410.33 due to a decrease in receivables and the reversal of bad debt provisions[10]. - Asset impairment losses decreased by 4,378.31% to CNY -53,955,391.28, primarily due to significant declines in product prices and large inventory write-downs[10]. - Cash received from government subsidies related to operating activities increased by 55.94% to CNY 87,080,270.16, reflecting higher deferred income from government support[10]. - Cash received from investment income rose by 40.05% to CNY 29,082,226.10, attributed to increased dividends from long-term equity investments[10]. - Cash paid for fixed assets and intangible assets decreased by 43.05% to CNY 146,908,290.76, indicating reduced project investments during the reporting period[10]. - The company reported a significant decrease in other operating expenses, down 95.77% to CNY 58,206.03, compared to the previous year[10]. - The company paid 202,613,824.39 CNY in employee compensation, down from 230,107,253.43 CNY in the prior period[22].
闽发铝业(002578) - 2025 Q3 - 季度财报
2025-10-24 13:05
福建省闽发铝业股份有限公司 2025 年第三季度报告 证券代码:002578 证券简称:闽发铝业 公告编号:2025-041 福建省闽发铝业股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 福建省闽发铝业股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 507,502,664.30 | -12 ...
歌尔股份(002241) - 2025 Q3 - 季度财报
2025-10-24 12:55
Financial Performance - The company's revenue for Q3 2025 reached ¥30,557,096,441.15, representing a year-on-year increase of 4.42%[5] - Net profit attributable to shareholders was ¥1,170,612,428.68, up 4.51% compared to the same period last year[5] - The net profit excluding non-recurring gains and losses was ¥1,033,537,300.91, reflecting a significant increase of 19.91% year-on-year[5] - The basic earnings per share for Q3 2025 was ¥0.34, a 3.03% increase year-on-year[5] - The net profit for the current period is CNY 2,546,835,375.33, an increase of 11.3% compared to CNY 2,288,241,601.26 in the previous period[26] - Operating profit for the current period is CNY 2,960,658,357.35, representing a growth of 17.4% from CNY 2,521,256,259.63 in the previous period[26] - Basic and diluted earnings per share increased to CNY 0.75, compared to CNY 0.69 in the previous period[27] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥94,822,692,862.82, an increase of 14.65% from the end of the previous year[5] - Total liabilities increased to ¥58,186,594,772.49 from ¥48,658,696,377.72, representing a rise of about 19.5%[23] - Total assets reached ¥94,822,692,862.82, up from ¥82,706,773,086.83, indicating an increase of approximately 14.7%[22] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥1,474,712,030.89, down 44.56% compared to the previous year[5] - Net cash flow from operating activities decreased by 44.56% to ¥1,474,712,030.89, mainly due to reduced cash receipts from sales and increased cash payments to employees[14] - Cash flow from operating activities generated a net amount of CNY 1,474,712,030.89, a decrease from CNY 2,659,949,622.83 in the previous period[30] - Cash flow from investing activities resulted in a net outflow of CNY 9,211,925,791.51, worsening from a net outflow of CNY 5,273,587,722.18 in the previous period[30] - Cash flow from financing activities generated a net inflow of CNY 10,456,595,825.23, compared to a net inflow of CNY 1,394,096,000.34 in the previous period[30] Investments - Long-term equity investments rose by 197.11% to ¥2,182,001,723.46, primarily due to new investments in Shanghai Connate Optical Technology Group[10] - Investment income surged by 996.09% to ¥399,953,040.11, primarily from foreign exchange derivatives and investments in associates[13] - Fair value changes in investment income rose by 128.75% to ¥457,716,706.98, attributed to increased gains from foreign exchange derivatives[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 319,047[16] - The largest shareholder, Goer Group Co., Ltd., holds 15.69% of shares, totaling 555,119,800 shares[16] - The company repurchased a total of 21,267,846 shares, accounting for 0.60% of the total share capital, with a total payment of ¥509,797,654.88[19] - The company plans to repurchase shares for an amount not less than ¥500 million and not exceeding ¥1 billion within 12 months[18] Revenue and Costs - Total revenue for the period was ¥68,106,589,959.32, a decrease of approximately 2.2% from ¥69,645,866,228.04 in the previous period[25] - Total operating costs amounted to ¥65,985,764,772.25, down from ¥67,266,555,187.01, reflecting a reduction of about 1.9%[25] - The company reported a decrease in sales revenue from CNY 57,335,511,243.50 to CNY 54,693,521,753.15, reflecting a decline of approximately 4.3%[29] Other Financial Metrics - The weighted average return on equity was 3.39%, a slight decrease of 0.13% compared to the same period last year[5] - Research and development expenses increased to CNY 3,979,777,137.50, up 19.3% from CNY 3,338,696,097.94 in the previous period[26] - Cash and cash equivalents increased to ¥19,522,187,128.76 from ¥17,466,492,869.05, representing a growth of approximately 11.8%[21] - Accounts receivable rose to ¥18,833,849,358.81, compared to ¥17,881,372,031.94, indicating an increase of about 5.3%[21] - Inventory surged to ¥16,273,722,781.85 from ¥10,478,868,878.63, marking a significant increase of approximately 55.5%[21]
大华股份(002236) - 2025 Q3 - 季度财报
2025-10-24 12:55
浙江大华技术股份有限公司 2025 年第三季度报告 证券代码:002236 证券简称:大华股份 公告编号:2025-084 □是 否 1 浙江大华技术股份有限公司 浙江大华技术股份有限公司 2025 年第三季度报告 2025 年第三季度报告 一、主要财务数据 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 适用 □不适用 | | | 单位:元 | | | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | 非流动性资产处置损益(包括已计提资产减值准备 | -1,533,630.98 | 483,831,482.50 | | | 的冲销部分) | | | | | 计入当期损益的政府补助 ...